Efficacy of Ozurdex in DME in the real world clinical setting-Leowenstein interview

Professor Anat Lowenstein talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.

Redirect to video article  


Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.